71366 Federal Register / Vol. 88, No. 198 / Monday, October 16, 2023 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–24–1359] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘National 

Survey of Syringe Services Programs 

(NSSSP)’’, to the Office of Management 

and Budget (OMB) for review and 

approval. CDC previously published a 

‘‘Proposed Data Collection Submitted 

for Public Comment and 

Recommendations’’ notice on May 4, 

2023, to obtain comments from the 

public and affected agencies. CDC 

received no public comments related to 

the previous notice. This notice serves 

to allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

The National Survey of Syringe 

Services Programs (NSSSP) (OMB 

Control No. 0920–1359, Exp. 12/31/ 

2024)—Revision—National Center for 

HIV, Viral Hepatitis, STD, TB 

Prevention (NCHHSTP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

The primary purpose of the National 

Survey of Syringe Services Programs 

(NSSSP) is to strengthen and improve 

the ability of CDC and local and state 

partners to monitor and evaluate syringe 

services programs (SSPs) nationally, 

with the overall goal of supporting, 

sustaining, and improving SSPs 

nationwide and reducing infectious 

disease and other harms related to drug 

use. Findings from the 2020–2021 

survey successfully characterized 

operational characteristics and services, 

funding resources, community relations, 

and key operational successes and 

challenges. The 2022 survey is currently 

being implemented. Revisions are being 

requested to address the increasing 

number of SSPs nationwide, the 

changing landscape of drug use 

nationally, additional SSP supplies and 

services provided, and ways in which 

SSPs are developing strategies to 

address the needs of people who use 

drugs (PWUD). 

The project will include all SSPs that 

are listed in a publicly available 

directory of all known SSPs in the 

United States maintained by the North 

American Syringe Exchange Network 

(NASEN; https://nasen.org). The project 

will also include SSPs in NASEN’s 

directory that do not wish to be publicly 

listed but have agreed to be contacted 

for research purposes, SSPs belonging to 

NASEN’s buyers’ club that are not part 

of the directory, respondents to prior 

RTI Arnold Ventures Surveys of SSPs 

that are not part of NASEN’s directory, 

and other SSPs proactively identified 

through searching state health 

department websites, funding agencies, 

state and regional networks, regional 

conferences, partner organization 

networks or webinars and via social 

media. SSPs will be sent a letter of 

invitation to participate in a 35-minute 

program survey. Participating programs 

will have the option of completing the 

survey via different modalities to 

enhance feasibility and comfort in 

completing the survey, for example via 

the Research Electronic Data Capture 

(REDCap) or a similarly secure webbased application. Other modalities for 

survey administration will include a 

coordinated telephone or 

videoconferencing interview. SSPs will 

be sent reminder letters for a six-month 

data collection period. SSPs that do not 

respond to prior reminders will be sent 

one final reminder, and if the SSP still 

does not want to participate, one 

(optional) question on why the SSP did 

not complete the survey will be offered. 

The survey will include questions on 

operational characteristics and services, 

funding resources, community relations, 

and key operational successes and 

challenges. Approximately 1000 SSPs 

will be able to participate in the survey. 

CDC anticipates that 20% of SSPs will 

decline to complete the survey, yielding 

800 completed surveys per year. 

However, given that it is challenging to 

predict future response rates, we are 

requesting enough burden hours to 

allow 100% of SSPs to respond to the 

survey. CDC estimates that it will take 

35 minutes to complete the survey, 

regardless of how the respondent 

chooses to complete it (i.e., selfadministered online or intervieweradministered by phone or 

videoconferencing). CDC estimates that 

it will take SSPs that do not respond to 

the initial survey invitation two minutes 

to respond to the additional question. 

CDC requests OMB approval for an 

estimated 616 annual burden hours. 

There are no other costs to respondents 

other than their time. 

Estimated Annualized Burden Hours 

Respondent Form Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

All participating SSPs .................................... National Syringe Services Program Evaluation Survey.1000 1 35/60 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 198 / Monday, October 16, 2023 / Notices 71367 

Respondent Form Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Non-responding SSPs ................................... Non-Response Survey Item .......................... 1000 1 2/60 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2023–22777 Filed 10–13–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10241 and CMS– 

10717] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by November 15, 

2023. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, please access the CMS PRA 

website by copying and pasting the 

following web address into your web 

browser: https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing. 

FOR FURTHER INFORMATION CONTACT: 

William Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Survey of Retail 

Prices; Use: This information collection 

request provides for a survey of the 

average acquisition costs of all covered 

outpatient drugs purchased by retail 

community pharmacies. CMS may 

contract with a vendor to conduct 

monthly surveys of retail prices for 

covered outpatient drugs. Such prices 

represent a nationwide average of 

consumer purchase prices, net of 

discounts and rebates. The contractor 

shall provide notification when a drug 

product becomes generally available 

and that the contract includes such 

terms and conditions as the Secretary 

shall specify, including a requirement 

that the vendor monitor the 

marketplace. CMS has developed a 

National Average Drug Acquisition Cost 

(NADAC) for states to consider when 

developing reimbursement 

methodology. The NADAC is a pricing 

benchmark that is based on the national 

average costs that pharmacies pay to 

acquire Medicaid covered outpatient 

drugs. This pricing benchmark is based 

on drug acquisition costs collected 

directly from pharmacies through a 

nationwide survey process. This survey 

is conducted on a monthly basis to 

ensure that the NADAC reference file 

remains current and up-to-date. Form 

Number: CMS–10241 (OMB control 

number 0938–1041); Frequency: 

Monthly; Affected Public: Private sector 

(Business or other for-profits); Number 

of Respondents: 72,000; Total Annual 

Responses: 72,000; Total Annual Hours: 

36,000. (For policy questions regarding 

this collection contact: Robert Giles at 

667–290–8626.) 

2. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Medicare Part C 

and Part D Program Audit and IndustryWide Part C Timeliness Monitoring 

Project (TMP) Protocols; Use: Under the 

Medicare Prescription Drug, 

Improvement, and Modernization Act of 

2003 and implementing regulations at 

42 CFR parts 422 and 423, Medicare 

Part D plan sponsors and Medicare 

Advantage organizations are required to 

comply with all Medicare Parts C and D 

program requirements. CMS’ annual 

audit plan ensures that we evaluate 

sponsoring organizations’ compliance 

with these requirements by conducting 

program audits that focus on high-risk 

areas that have the greatest potential for 

beneficiary harm. As such, CMS has 

developed the following audit protocols 

for use by sponsoring organizations to 

prepare for their audit: 

• Compliance Program Effectiveness 

(CPE) 

• Part D Formulary and Benefit 

Administration (FA) 

• Part D Coverage Determinations, 

Appeals, and Grievances (CDAG) 


ddrumheller on DSK120RN23PROD with NOTICES1